These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10914877)

  • 21. Pseudoporphyria from nonsteroidal anti-inflammatory drugs.
    Nicholls D
    N Z Med J; 1987 Jul; 100(827):427-8. PubMed ID: 3452072
    [No Abstract]   [Full Text] [Related]  

  • 22. Photosensitivity induced by naproxen.
    Gutiérrez-González E; Rodríguez-Pazos L; Rodríguez-Granados MT; Toribio J
    Photodermatol Photoimmunol Photomed; 2011 Dec; 27(6):338-40. PubMed ID: 22092742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nabumetone--a new NSAID.
    Med Lett Drugs Ther; 1992 Apr; 34(868):38-40. PubMed ID: 1556995
    [No Abstract]   [Full Text] [Related]  

  • 24. GI bleeding associated with nabumetone.
    Voss GD; Schweitzer P
    Am J Hosp Pharm; 1994 Oct; 51(19):2506, 2508. PubMed ID: 7847412
    [No Abstract]   [Full Text] [Related]  

  • 25. Drug induced pseudoporphyria.
    Ramsay CA
    J Rheumatol; 1991 Jun; 18(6):799-800. PubMed ID: 1895258
    [No Abstract]   [Full Text] [Related]  

  • 26. Cardiac arrest due to severe hyperkalaemia in patient taking nabumetone and low salt diet.
    Pal B; Hutchinson A; Bhattacharya A; Ralston A
    BMJ; 1995 Dec; 311(7018):1486-7. PubMed ID: 8520342
    [No Abstract]   [Full Text] [Related]  

  • 27. NSAIDs for the new decade--nabumetone?
    Huskisson EC
    Eur J Rheumatol Inflamm; 1991; 11(3):1-2. PubMed ID: 1365475
    [No Abstract]   [Full Text] [Related]  

  • 28. Rofecoxib-induced pseudoporphyria.
    Markus R; Reddick ME; Rubenstein MC
    J Am Acad Dermatol; 2004 Apr; 50(4):647-8. PubMed ID: 15034522
    [No Abstract]   [Full Text] [Related]  

  • 29. Tolerability of nabumetone: a pilot in vitro study showing absence of injury to articular cartilage.
    Giordano N; Senesi M; Battisti E; Gonnelli S; Franci B; Campagna MS; Mattii G; Palumbo F; Gennari C
    Int J Tissue React; 1996; 18(4-6):105-8. PubMed ID: 9195245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pseudoporphyria and nonsteroidal antiinflammatory agents in children with juvenile idiopathic arthritis.
    De Silva B; Banney L; Uttley W; Luqmani R; Schofield O
    Pediatr Dermatol; 2000; 17(6):480-3. PubMed ID: 11123786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pseudoporphyria induced by mefenamic acid.
    O'Hagan AH; Irvine AD; Allen GE; Walsh M
    Br J Dermatol; 1998 Dec; 139(6):1131-2. PubMed ID: 9990399
    [No Abstract]   [Full Text] [Related]  

  • 32. Gastroscopic evaluation of the effects of nabumetone on the gastrointestinal mucosa of rheumatic patients.
    Bianchi Porro G; Petrillo M; Ardizzone S; Caruso I; Montone F
    Eur J Rheumatol Inflamm; 1991; 11(3):38-42. PubMed ID: 1365479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypereosinophilic syndrome: endomyocardial fibrosis.
    Pitt M; Davies MK; Brady AJ
    Heart; 1996 Oct; 76(4):377-8. PubMed ID: 8983691
    [No Abstract]   [Full Text] [Related]  

  • 34. [Orthokin as new therapeutic option for orthopedic diseases].
    Heyll U
    Versicherungsmedizin; 2004 Mar; 56(1):30-2. PubMed ID: 15049471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pseudoporphyria due to naproxen.
    Lancet; 1985 May; 1(8438):1166-7. PubMed ID: 2860374
    [No Abstract]   [Full Text] [Related]  

  • 36. [Osteoarthritis and analgesic-antiphlogistic therapy. Preliminary report on the tolerability and efficacy of nabumetone treatment].
    Sartini S; Zuffa F; Menarini C; Vaiani G
    Clin Ter; 1990 Jul; 134(1):31-9. PubMed ID: 2147607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonsteroidal antiinflammatory drug-induced pseudoporphyria: a case series.
    LaDuca JR; Bouman PH; Gaspari AA
    J Cutan Med Surg; 2002; 6(4):320-6. PubMed ID: 12118363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pseudoporphyria secondary to non-steroidal anti-inflammatory drugs.
    Bryant P; Lachman P
    Arch Dis Child; 2003 Nov; 88(11):961. PubMed ID: 14612354
    [No Abstract]   [Full Text] [Related]  

  • 39. [Pseudoporphyria triggered by naproxen].
    Diernaes JE; Bustan R; Wasim D
    Ugeskr Laeger; 2016 Dec; 178(51):. PubMed ID: 28041539
    [No Abstract]   [Full Text] [Related]  

  • 40. [Properties and features of nabumetone].
    Davies NM; McLachlan AJ
    Drugs; 2000; 59 Spec No 1():25-33. PubMed ID: 10841070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.